2019
DOI: 10.1007/s12539-019-00339-6
|View full text |Cite
|
Sign up to set email alerts
|

Unearthing Regulatory Axes of Breast Cancer circRNAs Networks to Find Novel Targets and Fathom Pivotal Mechanisms

Abstract: Circular RNAs (circRNAs) along other complementary regulatory elements in ceRNAs networks possess valuable characteristics for both diagnosis and treatment of several human cancers including breast cancer (BC). In this study, we combined several systems biology tools and approaches to identify influential BC circRNAs, RNA binding proteins (RBPs), miRNAs, and related mRNAs to study and decipher the BC triggering biological processes and pathways.Rooting from the identified total of 25 co-differentially expresse… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
14
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(16 citation statements)
references
References 72 publications
2
14
0
Order By: Relevance
“…In our study, we identified 4 DEcircRNAs in the circRNA-miRNA- hub_gene network and found that hsa_circ_0001666 was downregulated in CRC tissues. This result is consistent with a recent study (30) indicating that hsa_circ_0001666 was downregulated in breast cancer tissues and may therefore play a key role in the development of breast malignancies. However, other circRNAs discovered in our ceRNA network have not been reported previously.…”
Section: Discussionsupporting
confidence: 93%
“…In our study, we identified 4 DEcircRNAs in the circRNA-miRNA- hub_gene network and found that hsa_circ_0001666 was downregulated in CRC tissues. This result is consistent with a recent study (30) indicating that hsa_circ_0001666 was downregulated in breast cancer tissues and may therefore play a key role in the development of breast malignancies. However, other circRNAs discovered in our ceRNA network have not been reported previously.…”
Section: Discussionsupporting
confidence: 93%
“…For example, miR-145-5p inhibited growth, migration and invasion of CRC [21,22]. Silencing miR-135b-5p sensitized CRC cells to oxaliplatin-induced apoptosis by upregulating FOXO1 expression [23].…”
Section: Discussionmentioning
confidence: 99%
“…Analysis of circulating microRNAs (cmiRNAs) before surgical operation (BSO) and after the surgical operation (ASO) has provided significant information for NSCLC diagnosis, progression, and outcomes of treatment [2]. One of the epigenetic biomarkers, known as cmiRNA, serves as a potential source for diagnosing NSCLC and its subtypes [3][4][5][6]. There are three important advantages in using cmiRNAs as a biomarker for NSCLC; they are as follows: (1) diagnostic feasibility from body fluids, (2) elevated stability and protection from endogenous enzymes (RNAase), and (3) accumulation of pathologic information from various tumorous sites, which overcomes the difficulty of tumor heterogenicity [7].…”
Section: Introductionmentioning
confidence: 99%